Reaction Details |
| Report a problem with these data |
Target | CTP synthase 2 |
---|
Ligand | BDBM50609669 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2278981 |
---|
IC50 | 710±n/a nM |
---|
Citation | Novak, A; Laughton, D; Lane, R; Blackham, E; Thomas, J; Chatzopoulou, E; Wrigglesworth, J; Quddus, A; Ahmed, S; Cousin, D; Duffy, L; Dubois, N; Unitt, J; Orban, K; Browne, E; Ward, M; Mycock, D; Ieva, M; Bland, N; George, P; Bourne, T; Asnagli, H; Birch, L; Jones, G Discovery and Optimization of Potent and Orally Available CTP Synthetase Inhibitors for Use in Treatment of Diseases Driven by Aberrant Immune Cell Proliferation. J Med Chem65:16640-16650 (2022) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
CTP synthase 2 |
---|
Name: | CTP synthase 2 |
Synonyms: | 6.3.4.2 | CTP synthase 2 | CTP synthetase 2 | CTPS2 | UTP--ammonia ligase 2 |
Type: | PROTEIN |
Mol. Mass.: | 65680.33 |
Organism: | Homo sapiens |
Description: | ChEMBL_120891 |
Residue: | 586 |
Sequence: | MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFV
LNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDA
VQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHV
SLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQ
VICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICS
IALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQK
LCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDAD
STEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRH
RFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPY
LGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS
|
|
|
BDBM50609669 |
---|
n/a |
---|
Name | BDBM50609669 |
Synonyms: | CHEMBL5288393 |
Type | Small organic molecule |
Emp. Form. | C19H25N3O4S2 |
Mol. Mass. | 423.549 |
SMILES | CCCOc1ccc(NC(=O)C(C)(C)c2csc(NS(=O)(=O)C3CC3)n2)cc1 |
Structure |
|